Spectrum Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Spectrum Management Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Hold	40	–	–	﹤0.01%	228
2022 Q2	$3K	Hold	40	–	–	﹤0.01%	229
2022 Q1	$4K	Buy	+40	New	+$3.69K	﹤0.01%	300

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Spectrum Management Group's XBI Position: Q3 2022 in Review

Spectrum Management Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2022 at 40 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Spectrum Management Group first reported a position in XBI in Q1 2022 and has held it in 3 quarters since. The position peaked at $4K in Q1 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Spectrum Management Group held 40 shares of State Street SPDR S&P Biotech ETF worth $3K as of Q3 2022.
Spectrum Management Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2022.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Spectrum Management Group's portfolio in Q3 2022, its #228 holding.
Spectrum Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 3 quarters since.
Spectrum Management Group's State Street SPDR S&P Biotech ETF position peaked at $4K in Q1 2022.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Spectrum Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.